Company

Executive Bios

Jean Amiral, PhD
Scientific and Research Director, HYPHEN BioMed (Neuville-Sur-Oise, France)

Competence: Immunologist, Biochemist, Doctor in Medical Sciences
Training: Biochemestry at the Lyon University-INSA (France), Immonology at the Medical School of Creteil (France), and PhD in Medical Sciences at Paris VII University
More than 20 years of experience in developing advanced assay methods for hemostasis and thrombosis; in designing new techniques for the measurement of coagulation factors and blood activation markers applied to the early diagnosis of cardiovascular alterations and thrombotic tendencies; research and development of assays for auto-immune diseases associated with an increased risk of thrombosis; direction of clinical and epidemiological studies; management of a research and technical group of 36 scientists; coordination of international collaborative studies; major involvement in scientific communication (presentations at congress and publications).
Original experience at the interface of fundamental research, technologies and clinical applications, with an expertise in thrombosis (causes and consequences) and its interactions.
Major accomplishments: Discovery of PF4 as the target antigen in presence of heparin, for Heparin Induced Anitbodies, type II, and description of immune pathological mechanisms; creation of HYPHEN BioMed in 1999, with Anne-Marie Vissac.
Personal: Born in 1952 in Barcelona, Spain; French citizen; married with two sons.

Ann Marie Vissac
Technical Director, HYPHEN BioMed

Competence: Coagulation and immunological technology; laboratory technical management; Biological Chemistry Engineer.
Training: Clinical Chemistry MT (ENC Paris, France); Biological Chemistry Engineer (SNIPF).
Experience: Microbiology teacher (ENC, Paris, 1976); Biological Analysis Laboratory (Drs. Samama and Kerboul, Paris, 1977 to 1986); project leader in Research and Development of Immunological methods (Serbio, Stago group, Gennevilliers, 1986 to 1998); Technical Director of HYPHEN Biomed (Neuville-Sur-Oise, from 1998); Presentations at International congresses, and author or co-author of various papers.
Practical experience in clinical applications of laboratory testing; development and validation of new assay methods, and especially immunoassays; epidemiological studies; clinical validation protocols. Complete experience in the field of laboratory techniques applied to the exploration of thrombosis, hemostasis and auto-immunity.
Major accomplishments: participation to the discovery of PF4 as the target antigen for Heparin Induced Antibodies in Jean Amiral's research group; creation of HYPHEN BioMed with Jean Amiral in 1999.
Personal: Born in Bastia (20 - France), in 1956; French citizen; married with a son and daughter.
Scientific and Research Director, HYPHEN BioMed (Neuville-Sur-Oise, France)